Loading clinical trials...
Loading clinical trials...
Observational Prospective Study to Analyze a Metabolomic Profile and to Explore it as Prognostic Factor in Patients With Renal Cell Carcinoma (mRCC)
Conditions
Locations
2
United Kingdom
Addenbrooke's Hospital
Cambridge, United Kingdom
Addenbrookes' Hospital
Cambridge, United Kingdom
Start Date
January 1, 2014
Primary Completion Date
October 1, 2015
Completion Date
December 1, 2015
Last Updated
June 23, 2015
NCT07485114
NCT06391099
NCT05738694
NCT07227402
NCT06349642
NCT07300241
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions